Intermittent corticosteroid therapy in serum hepatitis in preventing its progression to chronic hepatitis
โ Scribed by Matsuoka, M. ;Kanahara, T. ;Sato, A. ;Saito, H. ;Hirosawa, M. ;Isokawa, M. ;Sasai, K. ;Kubota, Y. ;Morisada, T.
- Publisher
- Springer-Verlag
- Year
- 1967
- Tongue
- English
- Weight
- 74 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Serum levels of antibody to hepatitis B core antigen and IgM antibody to hepatitis B core antigen were tested in 15 patients who participated in a randomized, placebo-controlled trial of a 28-day course of prednisolone therapy. During treatment, serum levels of antibody to hepatitis B core anti
## Abstract __Background__: Cytokines are known to play critical roles in the pathogenesis of chronic hepatitis B (CHB). However, the relationship between cytokines and treatment responses to drugs for CHB is not clearly defined yet. We measured the serum cytokine levels of interleukin (IL)โ1ฮฑ, ILโ
In a recent publication by Panzar et al., 1 the authors have 55. used 400-to 1,000-d polyethylene glycol to study small intes-4. Lake JR, Licko V, van Dyke RN, Scharschmidt BF. Biliary secretion of fluid-markers by the isolated perfused rat liver. J Clin Invest 1985;76:676-tinal absorption in portac